Teva Faces Second Trial Over Hepatitis Cases Linked to Drug Propofol

Bloomberg, August 19, 2011

Teva Pharmaceutical Industries Ltd. (TEVA), the world’s biggest generic-drug maker, sold the anesthetic propofol in a way that led some patients to develop hepatitis C, a lawyer said at the start of a second trial over the allegations. (Robert Eglet featured in article.)